Literature DB >> 32559410

The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.

Eduardo P Amaral1, Caian L Vinhaes2,3,4, Deivide Oliveira-de-Souza2,3,4, Betania Nogueira3,4,5, Kevan M Akrami3,5,6, Bruno B Andrade2,3,4,7,8,9,10.   

Abstract

Significance: Excessive and prolonged proinflammatory responses are associated with oxidative stress, which is commonly observed during chronic tuberculosis (TB). Such condition favors tissue destruction and consequently bacterial spread. A tissue remodeling program is also triggered in chronically inflamed sites, facilitating a wide spectrum of clinical manifestations. Recent Advances: Since persistent and exacerbated oxidative stress responses have been associated with severe pathology, a number of studies have suggested that the inhibition of this augmented stress response by improving host antioxidant status may represent a reasonable strategy to ameliorate tissue damage in TB. Critical Issues: This review summarizes the interplay between oxidative stress, systemic inflammation and tissue remodeling, and its consequences in promoting TB disease. We emphasize the most important mechanisms associated with stress responses that contribute to the progression of TB. We also point out important host immune components that may influence the exacerbation of cellular stress and the subsequent tissue injury. Future Directions: Further research should reveal valuable targets for host-directed therapy of TB, preventing development of severe immunopathology and disease progression. Antioxid. Redox Signal. 34, 471-485.

Entities:  

Keywords:  heme oxygenase; matrix metalloproteinase; oxidative stress; reactive oxygen species; tissue remodeling; tuberculosis

Mesh:

Year:  2020        PMID: 32559410      PMCID: PMC8020551          DOI: 10.1089/ars.2020.8124

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  138 in total

1.  Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients.

Authors:  Ensiyeh Seyedrezazadeh; Alireza Ostadrahimi; Soltanali Mahboob; Yagoob Assadi; Jamal Ghaemmagami; Masood Pourmogaddam
Journal:  Respirology       Date:  2008-03       Impact factor: 6.424

2.  Tuberculosis immunopathology: the neglected role of extracellular matrix destruction.

Authors:  Paul T Elkington; Jeanine M D'Armiento; Jon S Friedland
Journal:  Sci Transl Med       Date:  2011-02-23       Impact factor: 17.956

3.  Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β.

Authors:  Bibhuti B Mishra; Vijay A K Rathinam; Gregory W Martens; Amanda J Martinot; Hardy Kornfeld; Katherine A Fitzgerald; Christopher M Sassetti
Journal:  Nat Immunol       Date:  2012-11-18       Impact factor: 25.606

4.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Jerome B Zeldis; George Muller; Gilla Kaplan
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection.

Authors:  Deirdre M Kelly; Annemieke M C ten Bokum; Seonadh M O'Leary; Mary P O'Sullivan; Joseph Keane
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

6.  Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs.

Authors:  Soumya D Chakravarty; Guofeng Zhu; Ming C Tsai; Vellore P Mohan; Simeone Marino; Denise E Kirschner; Luqi Huang; Joanne Flynn; John Chan
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

7.  A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment.

Authors:  A Mosca; E Onelli; E Rosti; R Paleari; M Luzzana; B P Imbimbo
Journal:  Ther Drug Monit       Date:  1995-06       Impact factor: 3.681

Review 8.  Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis.

Authors:  Naveed Sabir; Tariq Hussain; Mazhar Hussain Mangi; Deming Zhao; Xiangmei Zhou
Journal:  Cell Prolif       Date:  2019-06-14       Impact factor: 6.831

9.  Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death.

Authors:  Minjian Chen; Maziar Divangahi; Huixian Gan; Daniel S J Shin; Song Hong; David M Lee; Charles N Serhan; Samuel M Behar; Heinz G Remold
Journal:  J Exp Med       Date:  2008-10-27       Impact factor: 14.307

10.  Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.

Authors:  G B Sigal; M R Segal; A Mathew; L Jarlsberg; M Wang; S Barbero; N Small; K Haynesworth; J L Davis; M Weiner; W C Whitworth; J Jacobs; J Schorey; D M Lewinsohn; P Nahid
Journal:  EBioMedicine       Date:  2017-10-24       Impact factor: 8.143

View more
  13 in total

1.  Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study.

Authors:  Andreea-Daniela Meca; Adina Turcu-Stiolica; Elena Camelia Stanciulescu; Ana Marina Andrei; Floarea Mimi Nitu; Ileana Monica Banita; Marius Matei; Catalina-Gabriela Pisoschi
Journal:  J Pers Med       Date:  2021-02-09

2.  Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania.

Authors:  Simona Ştefanescu; Relu Cocoş; Adina Turcu-Stiolica; Beatrice Mahler; Andreea-Daniela Meca; Ana Maria Cristina Giura; Maria Bogdan; Elena-Silvia Shelby; Georgeta Zamfirescu; Catalina-Gabriela Pisoschi
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

Review 3.  Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV.

Authors:  Caian L Vinhaes; Mariana Araujo-Pereira; Rafael Tibúrcio; Juan M Cubillos-Angulo; Fernanda O Demitto; Kevan M Akrami; Bruno B Andrade
Journal:  Life (Basel)       Date:  2021-01-18

4.  Editorial: Host-Directed Therapies for Tuberculosis.

Authors:  Diego L Costa; Mamoudou Maiga; Selvakumar Subbian
Journal:  Front Cell Infect Microbiol       Date:  2021-08-06       Impact factor: 5.293

5.  Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16- Monocytes From COVID-19 Patients.

Authors:  Silvia Lucena Lage; Eduardo Pinheiro Amaral; Kerry L Hilligan; Elizabeth Laidlaw; Adam Rupert; Sivaranjani Namasivayan; Joseph Rocco; Frances Galindo; Anela Kellogg; Princy Kumar; Rita Poon; Glenn W Wortmann; John P Shannon; Heather D Hickman; Andrea Lisco; Maura Manion; Alan Sher; Irini Sereti
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 6.  Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis.

Authors:  Reto Guler; Mumin Ozturk; Solima Sabeel; Bongani Motaung; Suraj P Parihar; Friedrich Thienemann; Frank Brombacher
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

7.  Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain.

Authors:  Jacqueline V Lara-Espinosa; María Fernanda Arce-Aceves; Manuel O López-Torres; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Barrios-Payán; Carlos Alfredo Silva-Islas; Perla D Maldonado; Brenda Marquina-Castillo; Rogelio Hernández-Pando
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 8.  All trans retinoic acid as a host-directed immunotherapy for tuberculosis.

Authors:  Ahmad Z Bahlool; Conor Grant; Sally-Ann Cryan; Joseph Keane; Mary P O'Sullivan
Journal:  Curr Res Immunol       Date:  2022-03-30

9.  Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia.

Authors:  Caian L Vinhaes; Rozana S Teixeira; Jay A S Monteiro-Júnior; Rafael Tibúrcio; Juan M Cubillos-Angulo; María B Arriaga; Adrielle G Sabarin; Amâncio J de Souza; Jacqueline J Silva; Isa M Lyra; Ana Marice Ladeia; Bruno B Andrade
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

10.  Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial.

Authors:  Izabella P Safe; Eduardo P Amaral; Mariana Araújo-Pereira; Marcus V G Lacerda; Vitoria S Printes; Alexandra B Souza; Francisco Beraldi-Magalhães; Wuelton M Monteiro; Vanderson S Sampaio; Beatriz Barreto-Duarte; Alice M S Andrade; Renata Spener-Gomes; Allyson Guimarães Costa; Marcelo Cordeiro-Santos; Bruno B Andrade
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.